RATIONALE: Recreational use of ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) has been associated with memory impairments. Functional neuroimaging studies with cross-sectional designs reported altered memory-related hippocampal functioning in ecstasy-polydrug users. However, differences might be pre-existing or related to the concomitant use of amphetamine. OBJECTIVE: To prospectively investigate the specific effects of ecstasy on memory-related hippocampal functioning. METHODS: We used an associative memory task and functional magnetic resonance imaging (fMRI) in 40 ecstasy and/or amphetamine users at baseline (t1) and after 12 months (t2). At t1, all subjects had very limited amphetamine and/or ecstasy experience (less than 5 units lifetime dose). Based on the reported drug use at t2, subjects with continued ecstasy and/or amphetamine use (n = 17) were compared to subjects who stopped use after t1 (n = 12). RESULTS: Analysis of repeated measures revealed that encoding-related activity in the left parahippocampal gyrus changed differentially between the groups. Activity in this region increased in abstinent subjects from t1 to t2, however, decreased in subjects with continued use. Decreases within the left parahippocampal gyrus were associated with the use of ecstasy, but not amphetamine, during the follow-up period. However, there were no significant differences in memory performance. CONCLUSIONS: The current findings suggest specific effects of ecstasy use on memory-related hippocampal functioning. However, alternative explanations such as (sub-)acute cannabis effects are conceivable.
RCT Entities:
RATIONALE: Recreational use of ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) has been associated with memory impairments. Functional neuroimaging studies with cross-sectional designs reported altered memory-related hippocampal functioning in ecstasy-polydrug users. However, differences might be pre-existing or related to the concomitant use of amphetamine. OBJECTIVE: To prospectively investigate the specific effects of ecstasy on memory-related hippocampal functioning. METHODS: We used an associative memory task and functional magnetic resonance imaging (fMRI) in 40 ecstasy and/or amphetamine users at baseline (t1) and after 12 months (t2). At t1, all subjects had very limited amphetamine and/or ecstasy experience (less than 5 units lifetime dose). Based on the reported drug use at t2, subjects with continued ecstasy and/or amphetamine use (n = 17) were compared to subjects who stopped use after t1 (n = 12). RESULTS: Analysis of repeated measures revealed that encoding-related activity in the left parahippocampal gyrus changed differentially between the groups. Activity in this region increased in abstinent subjects from t1 to t2, however, decreased in subjects with continued use. Decreases within the left parahippocampal gyrus were associated with the use of ecstasy, but not amphetamine, during the follow-up period. However, there were no significant differences in memory performance. CONCLUSIONS: The current findings suggest specific effects of ecstasy use on memory-related hippocampal functioning. However, alternative explanations such as (sub-)acute cannabis effects are conceivable.
Authors: Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton Journal: Psychopharmacology (Berl) Date: 2006-11-03 Impact factor: 4.530
Authors: Leo M Carusone; Jayashree Srinivasan; Darren R Gitelman; M Marsel Mesulam; Todd B Parrish Journal: AJNR Am J Neuroradiol Date: 2002-08 Impact factor: 3.825
Authors: T Schilt; M M L de Win; G Jager; M W Koeter; N F Ramsey; B Schmand; W van den Brink Journal: Psychol Med Date: 2007-11-08 Impact factor: 7.723
Authors: Maartje M L de Win; Gerry Jager; Jan Booij; Liesbeth Reneman; Thelma Schilt; Cristina Lavini; Sílvia D Olabarriaga; Gerard J den Heeten; Wim van den Brink Journal: Brain Date: 2008-10-07 Impact factor: 13.501
Authors: Philip Koester; Kirsten G Volz; Marc Tittgemeyer; Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann Journal: Neuropsychopharmacology Date: 2013-02-07 Impact factor: 7.853
Authors: Norbert Brüggemann; Marcus Heldmann; Andreas Sprenger; Jonas Repenthin; Thomas F Münte Journal: J Neurol Date: 2016-03-16 Impact factor: 4.849
Authors: Oliver G Bosch; Michael Wagner; Frank Jessen; Kai-Uwe Kühn; Alexius Joe; Erich Seifritz; Wolfgang Maier; Hans-Jürgen Biersack; Boris B Quednow Journal: PLoS One Date: 2013-04-09 Impact factor: 3.240
Authors: Kim P C Kuypers; Eef L Theunissen; Janelle H P van Wel; Elizabeth B de Sousa Fernandes Perna; Anke Linssen; Anke Sambeth; Benjamin G Schultz; Johannes G Ramaekers Journal: PLoS One Date: 2016-02-23 Impact factor: 3.240
Authors: Daniel Wagner; Simon Tkotz; Philip Koester; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann Journal: Front Neurosci Date: 2015-12-08 Impact factor: 4.677